Targeting Farnesoid X receptor (FXR) for developing novel therapeutics against cancer

Cancer is one of the lethal diseases that arise due to the molecular alterations in the cell. One of those alterations associated with cancer corresponds to differential expression of Farnesoid X receptor (FXR), a nuclear receptor regulating bile, cholesterol homeostasis, lipid, and glucose metaboli...

Descripción completa

Detalles Bibliográficos
Autores principales: Girisa, Sosmitha, Henamayee, Sahu, Parama, Dey, Rana, Varsha, Dutta, Uma, Kunnumakkara, Ajaikumar B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Singapore 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8607382/
https://www.ncbi.nlm.nih.gov/pubmed/35006466
http://dx.doi.org/10.1186/s43556-021-00035-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8607382/
https://www.ncbi.nlm.nih.gov/pubmed/35006466
http://dx.doi.org/10.1186/s43556-021-00035-2

Ejemplares similares